Unpuzzling COVID-19: tissue-related signaling pathways associated with SARS-CoV-2 infection and transmission

DS Battagello, G Dragunas, MO Klein… - Clinical …, 2020 - portlandpress.com
The highly infective coronavirus disease 19 (COVID-19) is caused by a novel strain of
coronaviruses–the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

[HTML][HTML] Molecular mechanisms of neuroinflammation in ME/CFS and long COVID to sustain disease and promote relapses

W Tate, M Walker, K Peppercorn… - Frontiers in neurology, 2022 - frontiersin.org
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a disease now well-
documented as having arisen commonly from a viral infection, but also from other external …

Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC)

S Mohandas, P Jagannathan, TJ Henrich, ZA Sherif… - Elife, 2023 - elifesciences.org
With a global tally of more than 500 million cases of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infections to date, there are growing concerns about the post …

Pathophysiological clues to how the emergent SARS-CoV-2 can potentially increase the susceptibility to neurodegeneration

M Dolatshahi, M Sabahi, MH Aarabi - Molecular neurobiology, 2021 - Springer
Along with emergence of the novel severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) in late 2019, a myriad of neurologic symptoms, associated with structural brain …

SARS-CoV-2, more than a respiratory virus: its potential role in neuropathogenesis

CMS Singal, P Jaiswal, P Seth - ACS chemical neuroscience, 2020 - ACS Publications
The coronavirus disease-19 (COVID-19) pandemic has emerged as one of the major
outbreaks to be mentioned in history in coming times. Like severe acute respiratory …

Potential neuroinvasive pathways of SARS‐CoV‐2: Deciphering the spectrum of neurological deficit seen in coronavirus disease‐2019 (COVID‐19)

AM Baig, EC Sanders - Journal of medical virology, 2020 - Wiley Online Library
Abstract Coronavirus disease‐2019 (COVID‐19) was declared a global pandemic on 11
March 2020. Scientists and clinicians must acknowledge that severe acute respiratory …

[HTML][HTML] Neuromechanisms of SARS-CoV-2: a review

MF DosSantos, S Devalle, V Aran, D Capra… - Frontiers in …, 2020 - frontiersin.org
Recent studies have suggested the neuroinvasive potential of severe acute respiratory
coronavirus 2 (SARS-CoV-2). Notably, neuroinvasiveness might be involved in the …

The neurological manifestations of post-acute sequelae of SARS-CoV-2 infection

N Moghimi, M Di Napoli, J Biller, JE Siegler… - Current Neurology and …, 2021 - Springer
Abstract Purpose of Review Coronavirus disease 2019 (COVID-19), caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global health challenge. This …

Innate immune response to SARS-CoV-2 infection: From cells to soluble mediators

D Ricci, MP Etna, F Rizzo, S Sandini, M Severa… - International journal of …, 2021 - mdpi.com
The vulnerability of humankind to SARS-CoV-2 in the absence of a pre-existing immunity,
the unpredictability of the infection outcome, and the high transmissibility, broad tissue …

Differential effects of SARS-CoV-2 variants on central nervous system cells and blood–brain barrier functions

A Proust, CJ Queval, R Harvey, L Adams… - Journal of …, 2023 - Springer
Background Although mainly causing a respiratory syndrome, numerous neurological
symptoms have been identified following of SARS-CoV-2 infection. However, how the virus …